Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs ...
Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs ...
Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...
Hikma's filing for a generic version of GlaxoSmithKline's Advair Diskus has been accepted by the FDA. The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretideâ„¢ or Advair ... the dose of Seretideâ„¢ administered via a Diskus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback